在瘤研究中评估FAPI PET/CT的诊断准确性:系统性审查和元分析

Grayson Wass1, Kari Clifford2, Rathan M Subramaniam3,4,5

  • 1Department of Medicine, Dunedin School of Medicine, University of Otago Medical School, Dunedin, New Zealand.

概括

与[18F]FDG PET/CT相比,纤维细胞激活蛋白抑制剂 (FAPI) PET/CT在检测癌症病变方面表现优越的诊断性能. 这种先进的成像技术为原发性瘤,淋巴结和转移提供了更高的灵敏度.